The results of the present study, which involved a larger group of Chinese patients with SLE, confirmed the finding that urinary angiostatin is a marker that can differentiate active renal from active non-renal SLE with a higher specificity/sensitivity than anti-dsDNA and complement C3. Here, PLG is linked to systemic lupus erythematosus.